세계의 창상관리 시장 : 유형별, 용도별, 최종사용자별(병원, 전문 클리닉/외래, 재택의료), 지역별 예측(-2032년)

Global Wound Care Market Research Report Information by Type (Classic Wound Care {Wound Cleanser, Wound Cleansing Sprays, Medical tapes & bandages}, Advanced Wound Care {Advanced Wound Dressings, Infection Management, Therapy Devices, Biologics, Debridement, Skin Prevention}), Application (Chronic Wound {Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Others}, Acute Wounds {Surgical, Burns, Trauma}), End User (Hospitals, Specialty Clinics / Ambulatory Market, Home Healthcare (OTC)), and by Region (North America, Europe, Asia-Pacific, and Rest Of The World-Forecast to 2032

Market Overview

In 2023, the wound care market was estimated to be worth USD 22.23 billion. In 2024, the Wound Care Market industry is anticipated to expand from USD 23.69 billion to USD 41.56 billion by 2032, with a compound annual growth rate (CAGR) of 6.45% over the forecast period (2024-2032). The global market is experiencing growth due to the increasing prevalence of acute and chronic wounds, the expanding geriatric population, reimbursements, and product launches.

The Wound Care Market is currently experiencing a significant increase in demand, which is primarily due to the increasing prevalence of acute and chronic lesions. The healthcare landscape is being transformed by a combination of factors, which is contributing to the increase in wound-related conditions. An increasing prevalence of chronic diseases, including cardiovascular disorders, obesity, and diabetes. Chronic wounds, such as diabetic foot ulcers and venous limb ulcers, are frequently the result of these conditions. Diabetes and kidney disease were responsible for approximately 2 million fatalities in 2019, as per the World Health Organization (WHO). Additionally, the increase in surgical procedures, which have ranged from elective surgeries to life-saving interventions, has required a more concentrated attention on post-operative wound care. In 2022, the number of procedures performed on the entire body and extremities increased by 25.3% in comparison to the previous year, as indicated by data from the International Society of Aesthetic Plastic Surgery (ISAPS). This has resulted in an ongoing demand for wound care products and solutions as the surgical patient population continues to grow. Additionally, the market for wound care may expand rapidly because of the increasing number of road accidents worldwide.

Market segment insights

The wound care market has been segmented into three categories: classic wound care, advanced wound care, and skin prevention.

the wound care market is divided into chronic wounds and acute wounds based on application.

The wound care market is segmented into three categories: hospitals, specialty clinics, and home healthcare, based on the end consumers.

Regional Perspectives

The market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World by region. North America held the greatest market share of over 36.60% in 2022 because of the growing number of patients with acute or chronic wounds in the region. As per Canada.ca, the prevalence of diabetes has increased at an annual rate of 3.3% after accounting for the ageing population, and it currently impacts over 3 million Canadians, or 8.9% of the population. Additionally, 6.1% of Canadian individuals have prediabetes, which increases their susceptibility to the development of type 2 diabetes.

because of the increasing number of government initiatives. Europe is estimated to have an approximated 15-20 million individuals with chronic wounds, according to the National Institute of Health. The United Nations Department of Economic and Social Affairs report, "World Population Ageing 2020 Highlights," predicts that there will be 727 million individuals aged 65 and older in the world by 2020. It is anticipated to increase by over twofold by 2050, with a population of nearly 1.5 billion. Moreover, the wound care market in Germany accounted for the largest market share in 2022, while the wound care market in Italy is the fastest-growing market in the European region.

The Asia-Pacific Wound Care market is expected to experience the most rapid growth during the forecast period due to the substantial patient population in Asian countries who are affected by chronic wounds. Additionally, the quality of healthcare is being improved by government initiatives, rising per capita income, and the number of diabetes cases. The aging population in China, India, and Australia has created a lucrative market for wound care. The geriatric population in the region is being supported by the increasing life expectancies, as indicated in the Asian Development Bank's report, "Impact of Population Aging on Asia's Future Growth."

Major Players

3M (US), Braun SE (Germany), Coloplast Group (Denmark), ETS Wound Care, LLC (US), Baxter (US), BD (US), Cardinal Health (US), Convatec Inc. (UK), Johnson & Johnson Services, Inc. (US), and Smith+Nephew (UK) are among the key companies in the wound care market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 INCREASING PREVALENCE OF ACUTE AND CHRONIC WOUNDS
  • 4.2.2 GROWING GERIATRIC POPULATION
  • 4.2.3 REIMBURSEMENTS AND PRODUCT LAUNCHES
• 4.3 RESTRAINTS
  • 4.3.1 DELAYED DIAGNOSIS OF CHRONIC WOUNDS IN EMERGING MARKETS LIMITS PRODUCT ADOPTION
• 4.4 OPPORTUNITY
  • 4.4.1 ADVANCED WOUND CARE SOLUTIONS

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D & DESIGNING
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION & SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL WOUND CARE MARKET
  • 5.3.1 IMPACT ON SUPPLY CHAIN
  • 5.3.2 IMPACT ON PRODUCTION
  • 5.3.3 IMPACT ON REGIONS
  • 5.3.4 IMPACT ON PRICING

6 GLOBAL WOUND CARE MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 CLASSIC WOUND CARE
  • 6.2.1 WOUND CLEANSER
    • 6.2.1.1 WOUND CLEANSING AND IRRIGATIONS SOLUTIONS
    • 6.2.1.2 WOUND CLEANSING GELS
  • 6.2.2 WOUND CLEANSING SPRAYS
  • 6.2.3 MEDICAL TAPES & BANDAGES
• 6.3 ADVANCED WOUND CARE
  • 6.3.1 ADVANCED WOUND DRESSINGS
    • 6.3.1.1 EXUDATE MANAGEMENT
    • 6.3.1.1.1 FOAM DRESSINGS
    • 6.3.1.1.2 ALGINATE DRESSINGS
    • 6.3.1.1.3 FILM DRESSINGS
    • 6.3.1.1.4 HYDROGELS
    • 6.3.1.1.5 COLLAGEN DRESSINGS
    • 6.3.1.1.6 HYDROCOLLOIDS
    • 6.3.1.1.7 SUPERABSORBANTS
    • 6.3.1.1.8 CONTACT LAYERS
    • 6.3.1.1.9 OTHERS WOUND DRESSINGS
  • 6.3.2 INFECTION MANAGEMENT
    • 6.3.2.1 NON-SILVER DRESSINGS
    • 6.3.2.2 SILVER DRESSINGS
  • 6.3.3 THERAPY DEVICES
    • 6.3.3.1 NPWT
    • 6.3.3.2 ELECTRICAL STIMULATION
    • 6.3.3.3 HBOT (HYPERBARIC BLOOD OXYGEN THERAPY)
  • 6.3.4 BIOLOGICS
    • 6.3.4.1 TOPICAL AGENTS
    • 6.3.4.2 SKIN SUBSTITUTES
    • 6.3.4.3 GROWTH FACTOR
  • 6.3.5 DEBRIDEMENT
    • 6.3.5.1 ULTRASOUND DEBRIDEMENT
    • 6.3.5.2 DEBRIDEMENT PADS, SWABS, CLOTHS
• 6.4 SKIN PREVENTION
  • 6.4.1 BARRIER CREAM & BARRIER SWABS
  • 6.4.2 EMOLLIENTS

7 GLOBAL WOUND CARE MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 CHRONIC WOUND
  • 7.2.1 DIABETIC FOOT ULCERS
  • 7.2.2 PRESSURE ULCERS
  • 7.2.3 VENOUS LEG ULCERS
  • 7.2.4 OTHERS
    • 7.2.4.1 ARTERIAL ULCERS
    • 7.2.4.2 NEUROPATHIC ULCERS
• 7.3 ACUTE WOUNDS
  • 7.3.1 SURGICAL
  • 7.3.2 BURNS
  • 7.3.3 TRAUMA

8 GLOBAL WOUND CARE MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 HOSPITALS
• 8.3 SPECIALTY CLINICS / AMBULATORY MARKET
• 8.4 HOME HEALTHCARE (OTC)

9 GLOBAL WOUND CARE MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 FRANCE
  • 9.3.3 UK
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 INDIA
  • 9.4.3 JAPAN
  • 9.4.4 AUSTRALIA
  • 9.4.5 SOUTH KOREA
  • 9.4.6 REST OF ASIA-PACIFIC
• 9.5 REST OF THE WORLD
  • 9.5.1 LATIN AMERICA
  • 9.5.2 MIDDLE EAST
  • 9.5.3 AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 COMPETITIVE BENCHMARKING
• 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL WOUND CARE MARKET
• 10.4 KEY DEVELOPMENT ANALYSIS
• 10.5 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL WOUND CARE MARKET
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL
  • 10.6.2 ACQUISITION
  • 10.6.3 ACQUISITION
• 10.7 MAJOR PLAYERS FINANCIAL MATRIX
  • 10.7.1 SALES (USD MILLION),
  • 10.7.2 R&D (USD MILLION),

11 COMPANY PROFILE

• 11.1 3M
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 NEW PRODUCTS VS BEST SELLER
  • 11.1.5 KEY DEVELOPMENTS
  • 11.1.6 SWOT ANALYSIS
  • 11.1.7 KEY STRATEGIES
• 11.2 B.BRAUN SE
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFERED
  • 11.2.4 NEW PRODUCTS VS BEST SELLER
  • 11.2.5 KEY DEVELOPMENTS
  • 11.2.6 SWOT ANALYSIS
  • 11.2.7 KEY STRATEGIES
• 11.3 COLOPLAST GROUP
  • 11.3.1 COMPANY OVERVIEWS
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 NEW PRODUCTS VS BEST SELLER
  • 11.3.5 KEY DEVELOPMENTS
  • 11.3.6 SWOT ANALYSIS
  • 11.3.7 KEY STRATEGIES
• 11.4 ETS WOUND CARE, LLC
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 NEW PRODUCTS VS BEST SELLER
  • 11.4.5 KEY DEVELOPMENTS
  • 11.4.6 KEY STRATEGIES
• 11.5 BAXTER
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 NEW PRODUCTS VS BEST SELLER
  • 11.5.5 KEY DEVELOPMENTS
  • 11.5.6 SWOT ANALYSIS
  • 11.5.7 KEY STRATEGIES
• 11.6 BD
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 NEW PRODUCTS VS BEST SELLER
  • 11.6.5 KEY DEVELOPMENTS
  • 11.6.6 KEY STRATEGIES
• 11.7 CARDINAL HEALTH
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 NEW PRODUCTS VS BEST SELLER
  • 11.7.5 KEY DEVELOPMENTS
  • 11.7.6 KEY STRATEGIES
• 11.8 CONVATEC INC.
  • 11.8.1 COMPANY OVERVIEWS
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 NEW PRODUCTS VS BEST SELLER
  • 11.8.5 KEY DEVELOPMENTS
  • 11.8.6 KEY STRATEGIES
• 11.9 JOHNSON & JOHNSON SERVICES, INC
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 NEW PRODUCTS VS BEST SELLER
  • 11.9.5 KEY DEVELOPMENTS
  • 11.9.6 KEY STRATEGIES
• 11.10 SMITH+NEPHEW
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 NEW PRODUCTS VS BEST SELLER
  • 11.10.5 KEY DEVELOPMENTS
  • 11.10.6 SWOT ANALYSIS
  • 11.10.7 KEY STRATEGIES
• 11.11 MEDTRONIC
  • 11.11.1 COMPANY OVERVIEWS
  • 11.11.2 FINANCIAL OVERVIEW
  • 11.11.3 PRODUCTS OFFERED
  • 11.11.4 NEW PRODUCTS VS BEST SELLER
  • 11.11.5 KEY DEVELOPMENTS
  • 11.11.6 KEY STRATEGIES

12 APPENDIX

• 12.1 REFERENCES
• 12.2 RELATED REPORTS